AR and prostate adenocarcinoma: Transcriptomic approaches, in the first case using microarrays and subsequently applying next generation sequencing (NGS) approaches, have established that PRAD cells display a remarkable diversity of AR transcriptional responses, and underscored that there are few examples of obligate and universal transcriptional responses regulated by the AR [14,15,16].